Technical Analysis for LNTH - Lantheus Holdings, Inc.

Grade Last Price % Change Price Change
grade A 16.57 0.42% 0.07
LNTH closed up 0.42 percent on Friday, January 18, 2019, on 66 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical LNTH trend table...

Date Alert Name Type % Chg
Jan 18 Narrow Range Bar Range Contraction 0.00%
Jan 18 NR7 Range Contraction 0.00%
Jan 18 Inside Day Range Contraction 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 17 Overbought Stochastic Strength 0.42%
Jan 16 Shooting Star Candlestick Bearish -0.30%
Jan 16 Stochastic Sell Signal Bearish -0.30%
Jan 16 Lizard Bearish Bearish Day Trade Setup -0.30%
Jan 16 Overbought Stochastic Strength -0.30%
Jan 16 Up 3 Days in a Row Strength -0.30%

Older signals for LNTH ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Lantheus Holdings, Inc. is engaged in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases. The Company's medical imaging agents are used to diagnose coronary artery disease, congestive heart failure, stroke, peripheral vascular disease and other diseases. The Company's products include contrast agents and medical radiopharmaceuticals, including technetium generators. The Company's products include DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, Neurolite, Thallium Tl 201, Gallium Ga 67, Gludef, Quadramet and Ablavar. The Company is also engaged in developing agents, such as Flurpiridaz F 18, which is a myocardial perfusion imaging agent; 18F LMI 1195, which is a cardiac neuronal imaging agent, and LMI 1174, which is a vascular remodeling imaging agent.
Is LNTH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 24.45
52 Week Low 12.59
Average Volume 223,789
200-Day Moving Average 15.1591
50-Day Moving Average 16.2416
20-Day Moving Average 15.65
10-Day Moving Average 16.289
Average True Range 0.5897
ADX 12.52
+DI 24.0196
-DI 19.8135
Chandelier Exit (Long, 3 ATRs ) 15.3609
Chandelier Exit (Short, 3 ATRs ) 15.5891
Upper Bollinger Band 17.1546
Lower Bollinger Band 14.1454
Percent B (%b) 0.81
BandWidth 19.228115
MACD Line 0.1373
MACD Signal Line 0.0085
MACD Histogram 0.1288
Fundamentals Value
Market Cap 618.89 Million
Num Shares 37.3 Million
EPS 0.73
Price-to-Earnings (P/E) Ratio 22.70
Price-to-Sales 2.17
Price-to-Book 0.00
PEG Ratio 0.69
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.98
Resistance 3 (R3) 16.97 16.84 16.91
Resistance 2 (R2) 16.84 16.73 16.84 16.88
Resistance 1 (R1) 16.70 16.67 16.77 16.71 16.86
Pivot Point 16.57 16.57 16.60 16.57 16.57
Support 1 (S1) 16.43 16.46 16.50 16.44 16.28
Support 2 (S2) 16.30 16.40 16.30 16.26
Support 3 (S3) 16.16 16.30 16.23
Support 4 (S4) 16.17